May 31, 2018 - More people than ever are being diagnosed with diabetes, and big advances in treatment could make these diabetes stocks savvy investments.
May 31, 2018 - The FDA approves Pfizer's (PFE) sNDA seeking label expansion in third indication for Xeljanz to include moderately to severely active ulcerative colitis.
May 30, 2018 - Identifying businesses built for growth is easy once you know where to look.
May 29, 2018 - Why an airplane giant, a drugmaker, and an alcoholic beverage specialist could each see more market-thumping gains ahead.
May 25, 2018 - This biotech stock is skyrocketing. Here's why -- maybe.
May 25, 2018 - Management's bold moves have been steadily stemming concerns about the company's future.
May 25, 2018 - The Dow endured another volatile week marked by key geopolitical developments.
May 25, 2018 - AbbVie's (ABBV) phase III iLLUMINA study evaluating Imbruvica in combination with Gazyva meets its primary endpoint of improvement in progression-free survival.
May 24, 2018 - Novartis' (NVS) Sandoz wins approval for a biosimilar version of Remicade in Europe, which should further strengthen its biosimilars portfolio.
May 23, 2018 - Geron's stock is blasting higher this week, but the exact reason isn't clear.